Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 113.

https://doi.org/10.1182/blood-2019-123047

Published: 2019

Journal Articles

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Tilmann Bochtler, MD, Martin Granzow, PhD, Friedrich Stölzel, MD, Christina Kunz, PhD, Brigitte Mohr, PhD, Mutlu Kartal-Kaess, MD, Johannes W.G. Janssen, PhD, Christoph E. Heilig, MD, Michael Kramer, MSc, Christian Thiede, MD, Axel Benner, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Anna Jauch, PhD, Alwin Krämer, MD

Blood (2016) 128 (22): 2869.

https://doi.org/10.1182/blood.V128.22.2869.2869

Published: 2016

Journal Articles

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Uta Oelschlaegel, PhD, Theresia M. Westers, PhD, Brigitte Mohr, PhD, Ulrika Johansson, PhD, Dolores Subira, PhD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Arjan A van de Loosdrecht, MD PhD, Uwe Platzbecker, MD

Blood (2016) 128 (22): 3179.

https://doi.org/10.1182/blood.V128.22.3179.3179

Published: 2016

Journal Articles

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Katja Sockel, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Uwe Platzbecker

Blood (2016) 128 (22): 5531.

https://doi.org/10.1182/blood.V128.22.5531.5531

Published: 2016

Journal Articles

Differential Distribution of Clonal Hematopoiesis in Flow-Sorted Subpopulations of Patients with Myelodysplastic Syndromes (MDS)

Maximilian Alexander Röhnert, Uwe Platzbecker, MD, Uta Oelschlägel, PhD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Brigitte Mohr, PhD

Blood (2014) 124 (21): 4626.

https://doi.org/10.1182/blood.V124.21.4626.4626

Published: 2014

Journal Articles

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Uta Oelschlaegel, PhD, Brigitte Mohr, PhD, Michael Kramer, PhD, Stefani Parmentier, MD, Katja Sockel, MD, Christian Thiede, MD, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Uwe Platzbecker, MD, PhD

Blood (2013) 122 (21): 2780.

https://doi.org/10.1182/blood.V122.21.2780.2780

Published: 2013

Journal Articles

Karyotypic Complexity In Acute Myeloid Leukemia In The Context Of Adverse Prognosis

Friedrich Stölzel, MD, Brigitte Mohr, PhD, Michael Kramer, PhD, Christoph Röllig, MD, Tilmann Bochtler, MD, Alwin Krämer, MD, Uta Oelschlägel, PhD, Jan Moritz Middeke, MD, Uwe Platzbecker, MD, PhD, Markus Schaich, MD, Johannes Schetelig, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD

Blood (2013) 122 (21): 489.

https://doi.org/10.1182/blood.V122.21.489.489

Published: 2013

Journal Articles

The Prognostic Impact of the Revised IPSS Cytogenetic Scoring System for Patients with MDS Allows a Risk-Stratification for Patients with MDS-Derived Acute Myeloid Leukemia

Friedrich Stölzel, MD, Michael Kramer, Brigitte Mohr, PhD, Martin Wermke, MD, Martin Bornhäuser, MD, Gerhard Ehninger, Markus Schaich, MD, Uwe Platzbecker, MD

Blood (2012) 120 (21): 1715.

https://doi.org/10.1182/blood.V120.21.1715.1715

Published: 2012

Journal Articles

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

Stefani Parmentier, MD, Michael Kramer, Katharina Koch, Brigitte Mohr, PhD, Christian Klesse, Christian Thiede, Christoph Röllig, Mathias Hänel, MD, Norbert Schmitz, MD, Kerstin Schäfer-Eckart, Walter E. Aulitzky, Wolfgang E. Berdel, MD, Hubert Serve, Prof. Dr. med., Stefan W. Krause, Jiri Mayer, MD, Martin Bornhäuser, MD, Gerhard Ehninger, Markus Schaich, MD

Blood (2012) 120 (21): 1481.

https://doi.org/10.1182/blood.V120.21.1481.1481

Published: 2012

Journal Articles

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Sylvia Herold, PhD, Matthias Kuhn, Uwe Platzbecker, MD, Stange Thoralf, Jörgen Radke, MD, Caroline Heiderich, Lange Thoralf, MD, Kerstin Gutsche, MD, Johannes Schetelig, Stefani Parmentier, MD, Brigitte Mohr, PhD, Markus Schaich, MD, Hubert Serve, Prof. Dr. med., Christian H. Brandts, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede

Blood (2012) 120 (21): 886.

https://doi.org/10.1182/blood.V120.21.886.886

Published: 2012

Journal Articles

Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.

Markus Andreas Schaich, MD, Monika Fuessel, PhD, Martin Bornhaeuser, MD, Christian Thiede, MD, Brigitte Mohr, PhD, Thomas Illmer, MD, Ulrike Schaekel, MD, Gabriele Prange-Krex, MD, Uta Oelschlaegel, PhD, Gerhard Ehninger, MD, on behalf of the DSIL AML2003 study group

Blood (2004) 104 (11): 2767.

https://doi.org/10.1182/blood.V104.11.2767.2767

Published: 2004

NARROW

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Flow Cytometric Response Monitoring in MDS with Del(5q) Using a Simple 5-Parameter-Score - an Elnet Imds-Flow Experience

Implementation of Diagnostic Flow Cytometry Allows for the Dissection of Age Related Loss of Y Chromosome from Myelodysplastic Syndrome (MDS)

Differential Distribution of Clonal Hematopoiesis in Flow-Sorted Subpopulations of Patients with Myelodysplastic Syndromes (MDS)

A Distinct Immunophenotypic Profile Of Del(5q) MDS Allows For Fast Monitoring Of Response To Treatment With Lenalidomide Or Azacitidine

Karyotypic Complexity In Acute Myeloid Leukemia In The Context Of Adverse Prognosis

The Prognostic Impact of the Revised IPSS Cytogenetic Scoring System for Patients with MDS Allows a Risk-Stratification for Patients with MDS-Derived Acute Myeloid Leukemia

Acute Erythroleukemia Morphology Does Not Confer an Unfavourable Prognosis in Itself. Results of a Subgroup Analysis of the Prospective Randomized AML96-, AML2003 and AML60+ Studies of the Study Alliance Leukemia (SAL)

A Unique Case of a Donor Cell Acute Myeloid Leukemia Reveals Complex Kinetics of Mutations and Evolution of the Disease

Rapid Risk-Profiling Including Fast Donor Search within a Multi-Center Trial Allows for Early Allogeneic Stem Cell Transplantation during Aplasia in Patients with High-Risk Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only